PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 1.809
EU - Europa 1.648
AS - Asia 884
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 4.349
Nazione #
US - Stati Uniti d'America 1.804
CN - Cina 379
UA - Ucraina 366
IE - Irlanda 312
TR - Turchia 292
SE - Svezia 253
GB - Regno Unito 202
FR - Francia 140
DE - Germania 130
SG - Singapore 108
IN - India 92
IT - Italia 86
FI - Finlandia 82
RU - Federazione Russa 59
BE - Belgio 7
CA - Canada 5
EU - Europa 5
IL - Israele 5
CZ - Repubblica Ceca 4
IR - Iran 4
PL - Polonia 2
AT - Austria 1
AU - Australia 1
CG - Congo 1
CL - Cile 1
EE - Estonia 1
JO - Giordania 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 4.349
Città #
Jacksonville 411
Chandler 365
Dublin 310
Southend 172
Izmir 147
Princeton 143
Wilmington 105
Nanjing 102
Singapore 82
Dearborn 75
Beijing 72
Ashburn 67
Cambridge 67
Ann Arbor 41
Nanchang 36
Woodbridge 35
Altamura 29
Shenyang 23
Kunming 21
Jiaxing 18
Boardman 17
Grevenbroich 17
Hebei 17
Helsinki 16
Changsha 15
Washington 15
Augusta 13
Norwalk 13
Santa Clara 13
Chieti 12
Houston 12
Los Angeles 12
Moscow 12
Tianjin 12
New York 10
San Mateo 10
Falls Church 9
Hangzhou 9
Munich 9
Orange 8
Brussels 7
Jinan 7
Lanzhou 7
Leawood 7
Seattle 6
Shanghai 5
Zhengzhou 5
Brno 4
Hefei 4
Tavagnacco 4
Toronto 4
Kocaeli 3
Mountain View 3
Pune 3
San Jose 3
Taiyuan 3
Tappahannock 3
Bologna 2
Changchun 2
Chaoyang 2
Guangzhou 2
Haikou 2
Kraków 2
Lanciano 2
Ningbo 2
Perugia 2
Secaucus 2
Simi Valley 2
Spoltore 2
Teramo 2
Adelaide 1
Auburn Hills 1
Bangalore 1
Belgrade 1
Bellante 1
Brazzaville 1
Buffalo 1
Catania 1
Chicago 1
Chongqing 1
Clearwater 1
Durham 1
Edinburgh 1
Frankfurt am Main 1
Fuzhou 1
Greifswald 1
Hanoi 1
Hanover 1
Karak 1
La Canada Flintridge 1
Lahore 1
Lake Forest 1
Louisville 1
Melita 1
Milan 1
Monmouth Junction 1
New Delhi 1
Newark 1
Newcastle Upon Tyne 1
Ottawa 1
Totale 2.706
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 116
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 103
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 102
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 102
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 91
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 89
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 88
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 85
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 84
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 82
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 77
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 76
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 76
Aspirin, platelet inhibition and cancer prevention. 76
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 75
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 71
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 71
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 71
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 70
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 69
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 69
Determinants of platelet activation in Alzheimer's disease 69
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Nutraceuticals in diabetes and metabolic syndrome. 68
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 68
Effects of nabumetone on prostanoid biosynthesis in humans. 67
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 66
Insulin resistance as a determinant of platelet activation in obese women. 66
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 65
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 65
Insulin resistance as a determinant of platelet activation in obese women 65
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 65
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 63
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 63
Role of Platelet Activation in Dementia 63
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 62
Mechanisms, consequences, and prevention of coronary graft failure 62
Increased thromboxane biosynthesis in essential thrombocythemia 61
Platelet activation in obese women: role of inflammation and oxidant stress. 61
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 61
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 60
Antiplatelet agents in the prevention of diabetic vascular complications 59
Determinants of Platelet Activation in Heart Failure. 58
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 57
Drugs, prostaglandins, and renal function. 57
Determinants of Platelet Activation in Heart Failure. 57
Determinants of platelet activation in human essential hypertension. 57
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 56
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 56
Soluble CD40L as an indicator of platelet Activation in Heart Failure 56
Cyclooxygenase-2 expression and inhibition in human monocytes 55
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 54
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 53
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 52
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 51
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 51
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 50
Thromboxane biosynthesis in cardiovascular diseases 50
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 49
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 48
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 47
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 46
Insulin resistance as a determinant of platelet activation in obese women 45
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 45
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 44
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 44
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 43
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 41
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 39
In vivo platelet activation in diabetes mellitus 31
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 10
Off-pump coronary artery bypass grafting: 30 years of debate 8
Totale 4.500
Categoria #
all - tutte 16.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020620 0 68 5 24 68 61 101 99 18 81 95 0
2020/2021456 70 1 72 1 26 100 3 4 79 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/2025220 95 125 0 0 0 0 0 0 0 0 0 0
Totale 4.500